Stocks
Arcutis Biotherapeutics (ARQT) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -135.2 | -206.5 | -205.6 | -294.6 | -227.4 | -142.0 | ||
| Changes by years, y/y, % | +223% | +53% | 0% | +43% | -23% | +63.1% | |||
Arcutis Biotherapeutics. EBITDA US GAAP, bln rub
Arcutis Biotherapeutics. EBITDA US GAAP, changes, %
Arcutis Biotherapeutics. EBITDA US GAAP, sum by quarters, bln rub
Arcutis Biotherapeutics (ARQT) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -58.1 | -31.3 | -27.2 | -44.5 | -39.1 | -142.0 | |
| Changes by years, y/y, % | -11% | -57% | -63% | -30% | +16% | |||
| Changes by quarters, q/q, % | +72% | -46% | -13% | +63% | -12% | |||
